These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24626870)

  • 1. Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge.
    Burns DL; Meade BD; Messionnier NE
    J Infect Dis; 2014 Apr; 209 Suppl 1():S32-5. PubMed ID: 24626870
    [No Abstract]   [Full Text] [Related]  

  • 2. Pertussis: pertussis control strategies and the options for improving current vaccines.
    Plotkin SA
    Expert Rev Vaccines; 2014 Sep; 13(9):1071-2. PubMed ID: 25090359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible options for new pertussis vaccines.
    Meade BD; Plotkin SA; Locht C
    J Infect Dis; 2014 Apr; 209 Suppl 1():S24-7. PubMed ID: 24626868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing pertussis epidemiology: everything old is new again.
    Clark TA
    J Infect Dis; 2014 Apr; 209(7):978-81. PubMed ID: 24626532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of improved vaccines against whooping cough: current status.
    Marzouqi I; Richmond P; Fry S; Wetherall J; Mukkur T
    Hum Vaccin; 2010 Jul; 6(7):543-53. PubMed ID: 20448470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-emergence of pertussis: what are the solutions?
    Libster R; Edwards KM
    Expert Rev Vaccines; 2012 Nov; 11(11):1331-46. PubMed ID: 23249233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerations.
    Farizo KM; Burns DL; Finn TM; Gruber MF; Pratt RD
    J Infect Dis; 2014 Apr; 209 Suppl 1():S28-31. PubMed ID: 24626869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we conquer coqueluche?
    Lynfield R; Schaffner W
    J Infect Dis; 2014 Apr; 209 Suppl 1():S1-3. PubMed ID: 24626865
    [No Abstract]   [Full Text] [Related]  

  • 10. Licensed pertussis vaccines in the United States. History and current state.
    Klein NP
    Hum Vaccin Immunother; 2014; 10(9):2684-90. PubMed ID: 25483496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resurgence of pertussis calls for re-evaluation of pertussis animal models.
    van der Ark AA; Hozbor DF; Boog CJ; Metz B; van den Dobbelsteen GP; van Els CA
    Expert Rev Vaccines; 2012 Sep; 11(9):1121-37. PubMed ID: 23151168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of improved pertussis vaccine.
    Rumbo M; Hozbor D
    Hum Vaccin Immunother; 2014; 10(8):2450-3. PubMed ID: 25424954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bordetella pertussis pathogenesis: current and future challenges.
    Melvin JA; Scheller EV; Miller JF; Cotter PA
    Nat Rev Microbiol; 2014 Apr; 12(4):274-88. PubMed ID: 24608338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foreword. Pertussis vaccines.
    Poolman JT
    Expert Rev Vaccines; 2014 Sep; 13(9):1067-9. PubMed ID: 25115214
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategies and new developments to control pertussis, an actual health problem.
    Gaillard ME; Bottero D; Moreno G; Rumbo M; Hozbor D
    Pathog Dis; 2015 Nov; 73(8):ftv059. PubMed ID: 26260328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live attenuated vaccines against pertussis.
    Locht C; Mielcarek N
    Expert Rev Vaccines; 2014 Sep; 13(9):1147-58. PubMed ID: 25085735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonhuman primate and human challenge models of pertussis.
    Merkel TJ; Halperin SA
    J Infect Dis; 2014 Apr; 209 Suppl 1(Suppl 1):S20-3. PubMed ID: 24626867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?
    van der Maas NA; Mooi FR; de Greeff SC; Berbers GA; Spaendonck MA; de Melker HE
    Vaccine; 2013 Sep; 31(41):4541-7. PubMed ID: 23933365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pertussis vaccine. Reemergence of the disease and new vaccination strategies].
    Moraga-Llop FA; Campins-Martí M
    Enferm Infecc Microbiol Clin; 2015 Mar; 33(3):190-6. PubMed ID: 25707329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies.
    Campbell PT; McCaw JM; McIntyre P; McVernon J
    Vaccine; 2015 Oct; 33(43):5794-5800. PubMed ID: 26392008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.